MKI67 and breast cancer: As a heterogeneous group of diseases, BC can be classified into various subtypes based on the expression levels of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and proliferation cell nuclear antigen (Ki67).